Skip to main content

Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studies.

Fuhrman BJ, Xu X, Falk RT, Hankinson SE, Veenstra TD, Keefer LK, Ziegler RG

Publication: Int J Biol Markers (2010) • Vol 25 • Page 185-94PMID: 21161939View on PubMed

Purpose

This paper investigated the effects of ascorbic acid preservation, storage at 4˚C, storage at -80˚C, and freeze-thaw cycling on levels of estrogen metabolites (EM) in urine. 

Conclusion

Although effects of storage on individual EM were noted for each of the three patients, no significant effect of storage at 4˚C for up to 48 h, storage at -80˚C for up to 1 year, or up to 3 freeze-thaw cycles was consistent across the patients. Importantly, the addition of ascorbic acid did not increase the stability of analytes and in the case of 4˚C storage, resulted in more analytes being significantly changed in urine from a single patient.

Studies (2)

Purpose

This study investigated the effects of ascorbic acid preservation, timing during menstrual cycle and storage at 4˚C for 48 h on levels of estrogen metabolites in urine. First morning urine was collected from two women during the luteal phase of the menstrual cycle and one woman in follicular phase of the menstrual cycle. Immediately after collection, the specimen was split and 0.1% (W/V) ascorbic acid was added to half while the other half of the specimen remained untreated. To investigate the effects of short-term refrigerated storage, six treated and six untreated aliquots from each patient were immediately frozen at -80˚C and three treated and three untreated aliquots from each patient were stored at 4˚C for 1, 2, 4, 8, 24, 32, or 48 hours before freezing at -80˚C. Estrogens and estrogen metabolites were quantified by LC-MS/MS.

Summary of Findings

As expected, urinary levels of estradiol and estrone were higher in the woman in the follicular phase of the menstrual cycle than in the two women in the luteal phase. Importantly, levels of individual estrogen metabolites in each individual varied by more than 2-orders of magnitude with 4-methoxyestradiol found at the lowest concentrations in all three patients, but different estrogen metabolites were found to be the most common in each of the three patients.

Short-term storage at 4˚C without ascorbic acid did not significantly affect levels of any analyte in specimens from all three patients but 2-hydroxyestradiol increased by 1.1% after 24 h (P=0.05) in one patient and estradiol concentrations declined by 0.1% in the first 24 h (P=0.04) in another patient. Similarly, when ascorbic acid was added, short-term storage at 4˚C did not affect levels of any one analyte in specimens from all three patients, but significant increases after 24 h were found for 4-methoxyestrone (6.6%, P<0.001), estriol (1.0%, P=0.01), and 16-epiestriol (0.5%, P=0.03) and significant declines after 24 h were found for 4-methoxyestradiol (5.7%, P trend= 0.03) for one patient and the other two patients had significant increases after 24 h in levels of 2-hydroxyestrone-3-methyl ether (1.1%, P=0.01 and 0.3% P=03). Specimens preserved with acetic acid showed smaller changes in 2-hydroxyestrone and larger changes in 2-hydroxyestrone-3-methyl ether, 4-methoxyestrone, and estriol during 4˚C storage in a single woman each.

  • Biospecimens

    FluidUrine
  • Preservation Types

    Frozen
  • Diagnoses

    Not specified
  • Platforms

    SteroidLC-MS or LC-MS/MS
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Follicular phase of menstrual cycle
    Luteal phase of menstrual cycle
    Biospecimen PreservationType of fixation/preservation
    Ascorbic acid
    Refrigeration
    StorageStorage duration
    1 h
    2 h
    24 h
    32 h
    4 h
    48 h
    8 h